The Core Facilities organisational unit has been awarded a grant worth €2.3 million for the project "HighWay2Cell - a platform for high resolution single cell omics" as part of the Austrian Research Promotion Agency's 2022 R&D infrastructure funding call. The platform will enable researchers to elucidate the spatial aspects of cell type heterogeneity and cell-cell interactions in diseased and healthy tissue samples by testing for the presence of a variety of proteins and for the expression of hundreds to thousands of transcripts of proteins with up to subcellular precision.With the grant, a cross-technology, multi-component, high-throughput platform for the spatial analysis of RNA and protein expression in biological samples at the single-cell level will be established in the Core Facilities. The platform will include imaging, single-molecule hybridization and supporting single-cell proteomics technology, enabling analysis of spatial gene and protein expression at the subcellular level. In addition to purchasing the necessary equipment, a high-performance computing cluster for data analysis will be implemented in cooperation with the ITSC of the Medical University of Vienna. For more information please click here.